Buscar | Boycat

Buscar

Rohit More @erth001 agregó una foto in Other
2026-06-17 05:23:36 · Translate ·

Adalimumab Biosimilar Market Accelerates as Cost-Effective Biologic Therapies Expand Access to Autoimmune Disease Treatment

According to the latest report published by Data Bridge Market Research, the Adalimumab Biosimilar Market Data Bridge Market Research analyses that the adalimumab biosimilar market which is USD 598.30 million in 2022, is expected to reach USD 3431.48 million by 2030, at a CAGR of 24.4% during the forecast period 2023 to 2030. For generating the Adalimumab Biosimilar...

0 Commentarios ·0 Acciones ·2K Views ·0 Vista previa

Please log in to like, share and comment!
Rohit More @erth001 agregó una foto in Other
2026-06-03 12:08:01 · Translate ·

Adalimumab Biosimilar Market Size, Share, Growth Trends, Industry Analysis, and Forecast 2026–2032 Driven by Rising Demand for Cost-Effective Biologic Therapies and Expanding Biosimilar Adoption

According to the latest report published by Data Bridge Market Research, the Adalimumab Biosimilar Market Data Bridge Market Research analyses that the adalimumab biosimilar market which is USD 598.30 million in 2022, is expected to reach USD 3431.48 million by 2030, at a CAGR of 24.4% during the forecast period 2023 to 2030. This Adalimumab Biosimilar Marketdocument provides with...

0 Commentarios ·0 Acciones ·3K Views ·0 Vista previa

Please log in to like, share and comment!
Rohit More @erth001 agregó una foto in Other
2026-06-17 05:29:44 · Translate ·

Janus Kinase (JAK) Inhibitor Drugs Market Advances with Expanding Use of Targeted Therapies for Autoimmune and Inflammatory Disorders

According to the latest report published by Data Bridge Market Research, the Janus Kinases (JAKs) Inhibitor Drugs Market Data Bridge Market Research analyses that the Janus kinases (JAKs) inhibitor drugs market, which is USD 2.45 billion in 2022, is expected to reach USD 5.11 billion by 2030, at a CAGR of 9.6% during the forecast period 2023 to 2030 Global Janus Kinases (JAKs)...

0 Commentarios ·0 Acciones ·1K Views ·0 Vista previa

Please log in to like, share and comment!
Rohit More @erth001 agregó una foto in Other
2026-06-04 07:38:01 · Translate ·

Janus Kinases (JAKs) Inhibitor Drugs Market Size, Share, Growth Trends, Industry Analysis, and Forecast 2026–2032 Driven by Rising Prevalence of Autoimmune Disorders and Advancements in Targeted Therapies

According to the latest report published by Data Bridge Market Research, the Janus Kinases (JAKs) Inhibitor Drugs Market Data Bridge Market Research analyses that the Janus kinases (JAKs) inhibitor drugs market, which is USD 2.45 billion in 2022, is expected to reach USD 5.11 billion by 2030, at a CAGR of 9.6% during the forecast period 2023 to 2030. This Janus Kinases (JAKs)...

0 Commentarios ·0 Acciones ·1K Views ·0 Vista previa

Please log in to like, share and comment!
Rohit More @erth001 agregó una foto in Other
2026-06-29 10:26:08 · Translate ·

Psoriatic Arthritis (PsA) Market Advances with Expanding Biologic Therapies and Personalized Treatment Approaches for Autoimmune Care

According to the latest report published by Data Bridge Market Research, the Psoriatic Arthritis (PsA) Market Global psoriatic arthritis (PsA) market size was valued at USD 14.74 billion in 2024 and is projected to reach USD 30.25 billion by 2032, with a CAGR of 9.40% during the forecast period of 2025 to 2032. The Psoriatic Arthritis (PsA) Market report not only benefits to save...

0 Commentarios ·0 Acciones ·915 Views ·0 Vista previa

Please log in to like, share and comment!